Biotech

All Articles

GSK's long-acting asthma drug halved attacks in stage 3

.GSK's long-acting asthma therapy has been presented to cut in half the variety of assaults in a set...

AstraZeneca, Daiichi unbox Dato-DXd's general survival neglect

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has failed to improve...

Roivant introduces brand new 'vant' to advance Bayer high blood pressure med

.Matt Gline is actually back along with a new 'vant' business, after the Roivant Sciences CEO paid f...

Viridian eye condition stage 3 smash hits, advancing press to rivalrous Amgen

.Viridian Therapies' stage 3 thyroid eye condition (TED) medical trial has actually struck its prima...

Bain reveals $3B fund permanently scientific research providers

.Along with a strong performance history for determining diamonds in the rough, Bain Capital Everyda...

Genentech's cancer cells restructure made 'for scientific reasons'

.The current selection to merge Genentech's 2 cancer cells divisions was actually created "clinical ...

Tern oral GLP-1 presents 5% fat burning at 1 month at highest possible dose

.Terns Pharmaceuticals' decision to fall its own liver ailment ambitions might yet pay off, after th...

Merck, Daiichi repeat very early excellence in tiny mobile lung cancer with improved ADC information

.Merck &amp Co.'s long-running initiative to land a punch on little tissue bronchi cancer (SCLC) has...

Boehringer, Bayer advance bronchi cancer cells medications toward Astra fight

.Some patients along with non-small cell bronchi cancer (NSCLC) have mutations in a gene named indiv...

MBX aims for $136M IPO to take rival to Ascendis into period 3

.MBX has fleshed out plannings to take in over $136 million coming from its own IPO as the biotech s...